SCHEMBL28904679

SCHEMBL28904679

Cc1ccc(S(=O)(=O)OC[C@H]2C[C@H]2C(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.47
CA2 P00918 6/20 0.47
STAT3 P40763 2/20 0.45
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
FFAR4 Q5NUL3 2/20 0.42
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
SIRT5 Q9NXA8 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 1/20 0.40
CYP2C9 P11712 1/20 0.40
KMT2A Q03164 1/20 0.40
CA9 Q16790 2/20 0.39
CA12 O43570 1/20 0.39
FFAR1 O14842 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30130355 0.86 STAT3 (0.43) CA1CA2STAT3TSHRSMN1; SMN2
SCHEMBL30636832 0.86 STAT3 (0.43) CA1CA2STAT3TSHRSMN1; SMN2
SCHEMBL3479184 0.85 TSHR (0.46) CA1CA2STAT3TSHRSMN1; SMN2
SCHEMBL20559391 0.85 ALDH1A1 (0.48) CA1CA2TSHRALDH1A1POLB
SCHEMBL4970833 0.85 ALDH1A1 (0.48) CA1CA2TSHRALDH1A1POLB
SCHEMBL26919725 0.80 STAT3 (0.42) CA1CA2STAT3ALDH1A1CTDSP1
SCHEMBL17815986 0.79 ALDH1A1 (0.49) CA1CA2STAT3TSHRALDH1A1
SCHEMBL19874149 0.78 STAT3 (0.40) CA1CA2STAT3TSHRSMN1; SMN2
SCHEMBL19874147 0.78 STAT3 (0.40) CA1CA2STAT3TSHRSMN1; SMN2
SCHEMBL25389881 0.78 STAT3 (0.44) STAT3TSHRALDH1A1POLBCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112105610-A Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation 朱比连特普罗德尔有限责任公司 2020-12-18 CN disclosed